As shown in an interesting murine melanoma model, VEGF-C activated LECs exhibit immunomodulatory functions by suppressing tumor-specific CD8+ T cells by lymphatic antigen presentation (Lund et al., 2012). Here, CD8A is linked to neoplasm.